The Neurology Advisor team will deliver comprehensive reports from AES 2025, held from December 5 to 9, in Atlanta, Georgia.

An FDA memo is creating controversy after an official said the COVID-19 vaccine may have played a role in the deaths of at least 10 children.

For the first time in more than 3 decades, the United States did not take part in World AIDS Day on December 1.

Exclusive AES 2025 coverage on medication-resistant epilepsy, wearable EEG technology for seizure detection, treatment for refractory status epilepticus, and more.

HealthDay News — Faster amyloid accumulation is seen over time among individuals with obesity, according to a study presented at the annual meeting of the Radiological Society of North America, held ...

A growing list of pots and pans is now considered unsafe, and the FDA is urging people to check their kitchens and get rid of them right away.

HealthDay News — Trajectories of long COVID have been identified, according to a study published online Nov. 17 in Nature Communications.

Longer PTR times during thrombectomy significantly increase the likelihood of death or hospice discharge and raise acute stroke care costs.

Measuring cognitive decline against premorbid ability removes racial differences after brain injury, indicating traditional test scores may reflect systemic bias.

Topline results from the RISE UP phase 3 trial demonstrated that mitapivat significantly improved hemoglobin response in patients with sickle cell disease.

The FDA has expanded the approval of Thrombate III to include pediatric patients with hATd to treat and prevent thromboembolism.

Oral semaglutide did not significantly reduce disease progression in patients with early Alzheimer disease, according to results from two phase 3 trials.